Akebia Therapeutics Inc Stock Performance
as on January 15, 2026 at 2:29 am IST
Day's Low
Day's High
$1.34$1.42
2.90%
Downside
2.90%
Upside
52 Week's Low
52 Week's High
$1.31$4.085.07%
Downside
195.56%
Upside
Akebia Therapeutics Inc share price movements today
- Previous Close
- $1.38
- Open
- $1.38
- Volume
- 3.2M
- Day's Low - High
- $1.34 - $1.42
- 52 Week Low - High
- $1.31 - $4.08
Akebia Therapeutics Inc Historical Returns
- 1 Month Return
- -16.87 %
- 3 Month Return
- -50.54 %
- 1 Year Return
- -26.98 %
- 3 Year Return
- + 98.56 %
- 5 Year Return
- -56.47 %
Akebia Therapeutics Inc Stock Fundamentals & Key Indicators
Check Akebia Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$371.5M
EPS (TTM)
0.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.78
Industry PE ratio
-2.428495575221239
PEG Ratio
0EBITDA
32.2M
Revenue (TTM)
225.1M
Profit Margin
-7.07%
Return On Equity TTM
-553.45%
Akebia Therapeutics Inc Stock Valuation
Track how Akebia Therapeutics Inc P/E has moved over time to understand its valuation trends.
Akebia Therapeutics Inc in the last 5 years
Lowest (-71.38x)
September 30, 2025
Today (-7.78x)
January 14, 2026
Industry (-2.43x)
January 14, 2026
Highest (39.21x)
December 31, 2025
Today’s Price to Earnings Ratio: -7.78x
Akebia Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Akebia Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $371.5M | -56.47% | -7.78 | -7.07% | |
| NA | $21.8B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.07 | 40.65% | |
| BUY | $43.6B | NA | 21.76 | 13.81% | |
| HOLD | $14.6B | -22.76% | -21.95 | -26.13% |
Stock Returns calculator for Akebia Therapeutics Inc Stock including INR - Dollar returns
The Akebia Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Akebia Therapeutics Inc investment value today
Current value as on today
₹77,343
Returns
Returns from Akebia Therapeutics Inc Stock
Dollar Returns*
₹4,327 (+4.33%)
Analyst Recommendation on Akebia Therapeutics Inc Stock
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Akebia Therapeutics Inc. Average target price of $5.4
Akebia Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Akebia Therapeutics Inc.
What analysts predicted
74.44%UPSIDE
Target Price
$5.4
Current Price
$1.38
Analyzed by
9 Analysts
Target
$5.40
Akebia Therapeutics Inc target price $5.4, a slight upside of 74.44% compared to current price of $1.38. According to 9 analysts rating.
Akebia Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Akebia Therapeutics Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Akebia Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Akebia Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Akebia Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Akebia Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Akebia Therapeutics Inc News & Key Events
Insights on Akebia Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 247.0K → 540.0K (in $), with an average increase of 54.3% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 4036.8% return, outperforming this stock by 3938.2%
- NO EFFECT
Against Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 25341.8% return, outperforming this stock by 25368.8%
NEGATIVE IMPACTPrice Dip
In the last 7 days, AKBA stock has moved down by -9.8%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 62.47M → 58.76M (in $), with an average decrease of 5.9% per quarter
About Akebia Therapeutics Inc
| Organisation | Akebia Therapeutics Inc |
| Headquarters | 245 First Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. John P. Butler MBA |
| E-voting on shares | Click here to vote |
Key Management of Akebia Therapeutics Inc
Name | Title |
|---|---|
Mr. Nicholas Grund | Senior VP & Chief Commercial Officer |
Ms. Kimberly Garko | Senior VP & Chief Technical Officer |
Ms. Carolyn Rucci | Senior VP of Legal, General Counsel & Secretary |
Dr. Steven Keith Burke M.D. | Senior VP and Chief Research & Development Officer |
Mr. Erik John Ostrowski M.B.A. | Chief Business Officer, Senior VP, CFO & Treasurer |
Mr. Richard C. Malabre | Chief Accounting Officer |
Ms. Tracey Vetterick | Vice President of Portfolio Strategy & Corporate Administration |
Mercedes Carrasco | Senior Director of Investor & Corporate Communications |
Ms. Meredith Bowman | Senior VP & Chief People Officer |
Mr. John P. Butler MBA | CEO, President & Director |
FAQs
What is Akebia Therapeutics Inc share price today?
Akebia Therapeutics Inc share price today is $1.38 as on at the close of the market. Akebia Therapeutics Inc share today touched a day high of $1.42 and a low of $1.34.
What is the 52 week high and 52 week low for Akebia Therapeutics Inc share?
Akebia Therapeutics Inc share touched a 52 week high of $4.08 on and a 52 week low of $1.31 on . Akebia Therapeutics Inc stock price today i.e. is closed at $1.38,which is 66.17% down from its 52 week high and 5.34% up from its 52 week low.
What is Akebia Therapeutics Inc's market capitalisation today?
Akebia Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Akebia Therapeutics Inc Stock (AKBA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Akebia Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akebia Therapeutics Inc Shares that will get you 1.0870 shares as per Akebia Therapeutics Inc share price of $1.38 per share as on January 15, 2026 at 2:29 am IST.
What is the minimum amount required to buy Akebia Therapeutics Inc Stock (AKBA) from India?
Indian investors can start investing in Akebia Therapeutics Inc (AKBA) shares with as little as ₹90.274 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.74 in Akebia Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akebia Therapeutics Inc share’s latest price of $1.38 as on January 15, 2026 at 2:29 am IST, you will get 7.2464 shares of Akebia Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Akebia Therapeutics Inc has given to Indian investors in the last 5 years?
Akebia Therapeutics Inc stock has given -56.47% share price returns and 23.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?